Health

Townsville Hospital Treats First Australian Patient With Elekta Unity MR-Linac, a Transformative Approach to Precision Radiation Therapy

Ability to adapt daily treatment based on real-time MR imaging enables new approach to hard-to-treat cancers TOWNSVILLE, Australia, Dec. 10, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced that Townsville Hospital inQueensland has treated the first patient in Australia using Elekta Unity ...

2019-12-10 08:13 6272

TechMah Medical & LimaCorporate Receive First 510k Approval for Smart SPACE Digital Technology

UDINE, Italy, Dec. 10, 2019 /PRNewswire/ -- LimaCorporate is pleased to announce the FDA510K approval for Smart SPACE Shoulder 3D Planner & 3D Positioner. Smart SPACE is an innovative digital platform developed by TechMah Medical thanks to collaboration with LimaCorporate, who entered into a mil...

2019-12-10 02:08 2283

Publication of First In-Human Data Reveals Safety & Efficacy of Tigilanol Tiglate in Solid Tumours

* First in-human Clinical Phase I study of intratumoural tigilanol tiglate (EBC-46) has been published in The Lancet's EBioMedicine journal; * An efficacious dose was achieved and a Maximum Tolerated Dose (MTD) was not reached, indicating tigilanol tiglate tolerability in humans; * Promising...

2019-12-09 21:01 1452

LPG SYSTEMS Unveils a Major Advancement: Irradiated Mastectomy Patients Can Benefit From Minimally Invasive Breast Reconstruction

NICE, France, Dec. 9, 2019 /PRNewswire/ -- A pilot study published in the Breast Journal shows the benefits of using Endermologie - a trademark of LPG SYSTEMS - in breast reconstruction after mastectomy and radiotherapy. This study included 65 women that had breast reconstruction with lipofilling...

2019-12-09 17:00 1679

PRC NHC Issues New Policy on Cord Blood Banks, Implementation Rules To Be Provided

HONG KONG, Dec. 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today reported thatChina's National Health Commission ("NHC") ...

2019-12-06 20:00 15362

CStone appoints seasoned pharmaceutical executive Shirley Zhao as the General Manager for Greater China and Head of Commercial

SUZHOU, China, Dec. 6, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced the appointment of Ms.Shirley Zhao to the position of General Manager forGreater China and Head of Commercial. In this position, Ms. Zhao will be responsible for the commerci...

2019-12-06 18:53 3779

CNN's 'Vital Signs with Dr. Sanjay Gupta' explores Traditional Chinese Medicine in Hong Kong

HONG KONG, Dec. 6, 2019 /PRNewswire/ -- There are few places in the world where modern and traditional intersect quite likeHong Kong, so what better place to explore the world of Traditional Chinese Medicine and ancient lifestyle practices. This month on CNN's 'Vital Signs' Dr.Sanjay Gupta travel...

2019-12-06 11:02 3364

Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-LAG-3 Monoclonal Antibody in China

SUZHOU, China, Dec. 6, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today a...

2019-12-06 08:00 12230

Neusoft Medical showcases new innovations at RSNA 2019

CHICAGO, Dec. 6, 2019 /PRNewswire/ -- RSNA 2019 marked Neusoft Medical's 20th year as an exhibitor. Neusoft Medical's diagnostic imaging solutions provide maximum value enabling healthcare providers to provide better care to their patients.  Neusoft Medical keeps exploring new innovations to meet...

2019-12-06 03:24 4350

Bill & Melinda Gates Foundation CEO Sue Desmond-Hellmann to Step Down, Longtime Foundation Executive Mark Suzman Appointed to Role

SEATTLE, Dec. 6, 2019 /PRNewswire/ -- Bill & Melinda Gates Foundation CEO Sue Desmond-Hellmann is stepping down after more than five years in the role. Bill and Melinda Gates have appointed Mark Suzman, the foundation's president of Global Policy & Advocacy and chief strategy officer, as the new ...

2019-12-06 02:41 3162

Chronolife Applauded by Frost & Sullivan for Flagship Predictive Health Analytics and Monitoring Smartwear

Chronolife's innovative T-shirt-based platform captures biometrics to track chronic conditions such as heart disease LONDON, Dec. 5, 2019 /PRNewswire/ -- Based on an in-depth analysis of the global predictive health analytics and monitoring market, Frost & Sullivan recognizesChronolife, a pionee...

2019-12-05 22:00 1047

Global Cord Blood Corporation Announces Results of 2019 Annual General Meeting

HONG KONG, Dec. 5, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2019 Annual Gene...

2019-12-05 21:30 13408

Suvoda Secures $40M Investment from LLR Partners

Growth capital to support expansion of Suvoda's clinical trial software and services CONSHOHOCKEN, Pennsylvania, Dec. 5, 2019 /PRNewswire/ -- Suvoda LLC, a SaaS provider of clinical trial software, announced it secured a$40 million minority equity investment fromPhiladelphia-based private equity...

2019-12-05 17:00 1589

Mayapada Clinic Accomplished Plenary Level Certification from the Accreditation Commission of the Ministry of Health

JAKARTA, Indonesia, Dec. 5, 2019 /PRNewswire/ -- Mayapada Clinic , which is part of Mayapada Healthcare, has accomplished Plenary Level Passed Certification from the First Level Health Facilities Accreditation Commission (FKTP- Fasilitas Kesehatan Tingkat Pertama) ...

2019-12-05 13:17 2331

Hummingbird Bioscience Raises US$19 Million in Series B Financing

SINGAPORE, Dec. 5, 2019 /PRNewswire/ -- Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery and development of new breakthrough precision antibody therapeutics for difficult-to-treat conditions, today announced that it has raisedUS$19 million in a Series B finan...

2019-12-05 10:00 1874

Biocon Biologics Takes Forward its Mission to Unlock Universal Access to Insulins Globally

BUSAN, South Korea, Dec. 5, 2019 /PRNewswire/ -- Biocon Biologics, a fully integrated 'pure play' global biosimilars organisation, is taking forward its mission of unlocking affordable access to quality insulins for people with diabetes across the world. As a credible, global insulins player, it ...

2019-12-05 09:00 1812

Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine

Newly updated and expanded NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic clarify who should be tested for cancer-causing genetic mutations Experts caution about risks of direct-to-consumer genetic testing and stress the importance of genetic counselin...

2019-12-04 22:01 999

FDA Grants Orphan Drug Designation to APR Applied Pharma Research's Investigational Drug for the Treatment of Epidermolysis Bullosa

BALERNA, Switzerland, Dec. 4, 2019 /PRNewswire/ -- APR Applied Pharma Research sa ("APR"), the Swiss pharma company focused in niche and rare therapeutic areas, announces that the US Food and Drug Administration (the "FDA") has granted Orphan Drug Designation for its investigational drug code-nam...

2019-12-04 19:22 2534

Ping An Good Doctor and Merck Form Strategic Collaboration to Advance Intelligent Healthcare in China

SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK), one of the world's leading healthcare ecosystem platforms, signed a strategic collaboration agreement today with Merck, a leading science and technology company....

2019-12-04 16:02 7476

Dong-A ST and Beactica Therapeutics Achieve Key Milestone in Their Collaboration to Develop New Cancer Treatments

STOCKHOLM, Dec. 4, 2019 /PRNewswire/ -- Dong-A ST Co., Ltd. (170900: Korea SE), a Korean pharmaceutical company, and Beactica Therapeutics AB, a Swedish drug discovery company, today announced that a lead compound meeting certain pre-defined criteria has been selected in their collaborative resea...

2019-12-04 15:26 1052